Patient characteristics and clinical information
| Patient | Age | Sex | Eye | Refraction | Initial VA | VA at follow up | Fellow eye | Duration follow up (months) | Presenting symptoms | Duration of symptoms | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|
| F, female; M, male; L, left; R, right; NIDDM, non insulin dependent diabetes; IIH, idiopathic intracranial hypertension. | |||||||||||
| 1 | 53 | F | R | −5.25 | 20/20 | 20/20 | 0 | Metamorphopsia | 12 months | ||
| 1 | 53 | F | L | −5.25 | 20/20 | 20/20 | 0 | Scotoma | 5 years | ||
| 2 | 55 | F | L | −1.0 | 20/30 | 20/30 | 20/20 | 0 | Metamorphopsia | Asymptomatic | Idiopathic finding |
| 3 | 31 | M | R | 0.0 | 20/16 | 20/16 | 20/16 | 36 | Scotoma | 10 years | Vague history of sun gazing during childhood |
| 4 | 57 | F | R | −1.25 | 20/30 | 20/25 | 20/16 | 96 | Scotoma | 7 years | |
| 5 | 29 | F | L | −0.5 | 20/30 | 20/16 | 20/16 | 27 | None | Asymptomatic | Idiopathic finding |
| 6 | 36 | F | R | −0.5 | 20/40 | 20/32 | 20/20 | 42 | Scotoma | 4 years | Glanced at eclipse protected |
| 7 | 28 | M | L | 0.0 | 20/30 | 20/30 | 20/16 | 0 | scotoma | 7 months | |
| 8 | 51 | M | R | 0.0 | 20/40 | 20/25 | 20/20 | 34 | Metamorphopsia | 4 years | |
| 9 | 57 | F | L | 0.75 | 20/40 | 20/63 | 20/25 | 7 | Scotoma | 3 years | |
| 10 | 53 | F | R | −0.5 | 20/60 | 20/50 | 20/16 | 3 | Scotoma | 12 months | Meningioma, glanced at eclipse protected |
| 11 | 61 | M | L | 1.0 | 20/40 | 20/40 | 20/16 | 0 | Scotoma | 18 months | Cortical lens opacity |
| 12 | 68 | F | R | 0.75 | 20/60 | 20/40 | 20/32 | 80 | Metamorphopsia | 8 years | Cortical lens opacity, macular pucker |
| 13 | 30 | F | L | −1.25 | 20/30 | 20/30 | 20/20 | 0 | Metamorphopsia | 36 months | |
| 14 | 77 | M | R | 1.75 | 20/40 | 20/40 | 20/25 | 0 | Scotoma | 6 months | |
| 15 | 49 | M | L | 0.0 | 20/30 | 20/40 | 20/16 | 80 | Scotoma | 10 years | NIDDM 2 years |
| 16 | 53 | M | R | −3.0 | 20/32 | 20/32 | 20/20 | 0 | Scotoma | 12 months | |
| 17 | 50 | F | R | 1.25 | 20/80 | 20/40 | 20/20 | 2 | Metamorphopsia, scotoma, and difficulty reading | 5 months | |
| 18 | 69 | M | R | 0.5 | 20/60 | 20/40 | 20/25 | 84 | Metamorphopsia | 4 years | NIDDM 4 years |
| 19 | 48 | M | R | −3.5 | 20/40 | 20/40 | 20/16 | 0 | Metamorphopsia | 11 months | |
| 20 | 50 | M | R | 0.25 | 20/20 | 20/80 | 74 | None | 6 months | Unexplained bilateral visual field loss | |
| 20 | 50 | M | L | 0.75 | 20/30 | 20/125 | 74 | Difficulty reading | 7 years | ||
| 21 | 35 | F | R | −1.5 | 20/30 | 20/30 | 20/16 | 0 | Scotoma | 12 months | IIH |
| 22 | 69 | M | R | −4.0 | 20/25 | 20/25 | 20/20 | 0 | Scotoma | 2 months | |